$SNPS

SYNOPSYS INC (SNPS): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

SYNOPSYS INC (SNPS) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. 8-K SYNOPSYS INC false 0000883241 0000883241 2026-08-09 2026-08-09 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reporte

Original reporting
Published Aug 12, 2026, 1:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 12, 2026, 1:26 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$SNPS
Neutral
medium confidence
Mentioned
$SNPS
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$SNPSNeutralLow
01

Why it matters

Janet Lee will stop serving as General Counsel and Corporate Secretary, moving to an advisory role until June 30, 2027 or later as determined by Synopsys, with an earlier effective date if a successor is appointed.

02

Market read

This is a governance and succession disclosure with a defined transition timeline, but no stated legal or financial shock in the text.

03

What to watch

Traders may want to watch for any later 8-K naming the successor and any concurrent changes to legal/compliance posture, especially if there are ongoing investigations not mentioned here.

Relevance 6/10Novelty 5/10Timing: today’s SEC 8-K filing, with effective date tied to Dec. 31, 2026 or successor appointment

Background

The filing is an SEC Form 8-K (Item 5.02) reporting the departure of a senior officer and related compensatory arrangements.

Company-level read

Ticker impact

$SNPSNeutralMedium confidence
Context

Synopsys disclosed in an 8-K that Janet Lee will step down as General Counsel and Corporate Secretary, effective the earlier of Dec. 31, 2026 or successor appointment.

Expected impact

Likely limited near-term impact; any repricing would depend on whether the successor is announced and whether the market views the transition as routine.

Evidence & confidence

The disclosure is a scheduled departure with an advisory transition period, and it does not include litigation, regulatory findings, or material financial terms.

Market effects

Minimal sector read-through; this is company-specific governance/leadership succession rather than a software-industry catalyst.

No clear regional spillover beyond US large-cap governance sentiment.

Low; the event is not tied to global regulatory actions, major contracts, or cross-border operations in the text.

Counterpoint

The transition could be routine succession planning, so the market may largely ignore it until the successor is named.

Key entities

  • Synopsys, Inc.

    US software company filing the 8-K reporting an officer departure and transition plan.

  • Janet Lee

    Outgoing General Counsel and Corporate Secretary, transitioning to an advisory role through mid-2027.

  • Shelagh Glaser

    CFO signing the 8-K on behalf of Synopsys.

Related articles

$SNPSHighAI 9/10

Dear Synopsys Stock Fans, Mark Your Calendars for August 26

Synopsys (SNPS) reported Q2 FY2026 revenue of $2.3B, up 41.9% YOY, beating estimates. Adjusted EPS was $3.35, down 8.7% YOY but above forecasts. Non-GAAP net income rose 12.4% YOY. The company raised full-year guidance, targeting $9.665B in revenue and $14.72-$14.80 in non-GAAP EPS. Analysts rate SNPS 'Strong Buy' with an average price target of $560, implying 35.5% upside.

$SNPSMedAI 8/10

Agentic AI Is Coming to Chip Design. Here Is Why Synopsys Stock Could Be the Biggest Beneficiary.

Synopsys raised its full-year fiscal 2026 revenue guidance midpoint to $9.665 billion and lifted non-GAAP EPS guidance to $14.76 at the midpoint, driven by strong first-half performance, accelerating Ansys integration synergies, and expanded operating margins. For Q3 fiscal 2026, management guided revenue of $2.41–$2.46 billion and non-GAAP EPS of $3.63–$3.69.

$SNPSMed

Synopsys Just Solved a Bottleneck You Didn’t Even Know Existed

Synopsys' valuation remains difficult to assess on its headline numbers. The forward GAAP price-to-earnings (P/E) makes it look extraordinarily expensive, while the price-to-sales (P/S) ratio does the opposite. The reason is the $35 billion Ansys acquisition. The forward P/E of 138.39x sits 91% above its 5-year average of 72.47x. The Ansys acquisition is holding down the reported earnings, making the stock look inflated.

$SNPSMed

Synopsys Doubles Down on AI Chip Design With Microsoft and AMD. How to Play SNPS Stock Here.

Synopsys (SNPS) shares rose more than 4% after the company unveiled autonomous AI workflows for chip design at the 2026 DAC Chips to Systems Conference. Synopsys said the workflows, built with Microsoft (MSFT) and evaluated by AMD (AMD), can cut debug cycles by 25% to 40%. SNPS reported fiscal Q2 2026 revenue of $2.27B and raised FY2026 outlook to about $9.665B revenue and $14.76 EPS.

$SNPSMed

Synopsys Certifies Its Chip Design Tools on Intel’s 14A Node

Synopsys said it certified its chip design toolchain for Intel’s (INTC) 14A process node, announced July 27, 2026. The certification covers digital and analog implementation, signoff, multiphysics analysis, and node-tuned interface and foundation IP, plus updates to its 3DIC Compiler for Intel packaging. Intel reported 14A foundry revenue not broken out, with $5.8B foundry revenue and a $2.09B operating loss in Q2 2026.